Cargando…
Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency
Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 (PD-1) antigen and induces an immune response against tumor tissues. It has been successful in inducing remission in patients with severe metastatic disease, often refractory to other chemotherapeutic ag...
Autores principales: | Hanna, Ramy M., Selamet, Umut, Bui, Patrick, Sun, Shih-Fan, Shenouda, Olivia, Nobakht, Niloofar, Barsoum, Marina, Arman, Farid, Rastogi, Anjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120420/ https://www.ncbi.nlm.nih.gov/pubmed/30197906 http://dx.doi.org/10.1159/000491631 |
Ejemplares similares
-
Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy
por: Hanna, Ramy M, et al.
Publicado: (2019) -
Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
por: Arman, Farid, et al.
Publicado: (2018) -
Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis
por: Hanna, Ramy M., et al.
Publicado: (2018) -
Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan
por: Hanna, Ramy M., et al.
Publicado: (2019) -
A Case of Kidney Involvement in Primary Sjögren’s Syndrome
por: Arman, Farid, et al.
Publicado: (2017)